October 5, 2018
Inaugural Accelerator Awards Announced!
1st Application Round (Spring 2018)
In spring 2018, the CBC has launched a new Accelerator Award program to support translational research and provide university researchers with “early commercial guidance.” Accelerator Awards aim to support the initial, and therefore highest risk, stage of commercially-directed research focused on the development of a therapeutic or an associated biomarker or diagnostic. The program encourages interactions between academic researchers and industry/pharmaceutical experts early in the development of projects and provides advice to award recipients in setting and progressing toward commercialization milestones. Award recipients will be mentored by faculty, industry experts, tech transfer officers and CBC personnel. Accelerator awardees will provide project updates at CBCAN meetings.
The CBC is pleased to announce that five teams received Accelerator Awards in the inaugural application round:
- PI: Chuan He (UChicago) for the project:
A Highly Sensitive and Robust Test for Early Colorectal Cancer Diagnosis - PI: Arnon Lavie (UIC) for the project:
Increasing the in vivo Stability of L-asparaginase through Interactions with HSA - PI: Yulia Komarova (UIC) for the project:
Development of Novel Treatment for Age-Related Macular Degeneration - PI: Brian Layden (UIC) for the project:
Novel FFA3 Antagonist Development for Type 2 Diabetes - PI: Richard Silverman (NU) for the project:
Novel Drug for Hepatocellular Carcinoma
Five awardees of the inaugural CBC Accelerator Award application, round 1 (Spring 2018). From the left: Chuan He (UChicago), Yulia Komarova (UIC), Arnon Lavie (UIC), Brian Layden (UIC) and Rick Silverman (NU).
See more:
▸ Accelerator Award RFA
▸ Past CBC Awards